Literature DB >> 28409242

Comparison of topical ropivacaine with and without ketamine on post-surgical pain in children undergoing tonsillectomy: a randomized controlled double-blind study.

Boohwi Hong1, Chae Seong Lim2, Yoon-Hee Kim1, Jung Un Lee1, Yong Min Kim3, Choonho Jung1, Yumin Jo1.   

Abstract

PURPOSE: Tonsillectomy in pediatric patients may cause severe postoperative pain. Topical local anesthetics are an easy and safe way to control post-tonsillectomy pain, but there is no benefit during the early postoperative stage. Topical ketamine shows a good effect on early stage postoperative pain. We compared the effect of topical ropivacaine with and without ketamine on post-tonsillectomy pain.
METHODS: Patients aged 3-7 years undergoing tonsillectomy were selected to participate in the study. Our study was performed in a randomized, placebo-controlled, double-blind manner. Patients were randomly assigned to one of two groups using computer-generated random numbers. The researchers who assessed the pain score, the caregivers, and the patient were blinded to group assignment. One group received topical ropivacaine with saline (RS group) and the other group received topical ropivacaine with 20 mg ketamine (RK group) on the tonsillar bed. Pain scores using the modified Children's Hospital of Eastern Ontario Pain Scale (mCHEOPS) at 15 min and 30 min, and at 1, 2, 4, 8, 16 and 24 h were recorded. Rescue analgesic requirement and complications were also recorded.
RESULTS: A total of 66 patients were randomly assigned to the RS group (n = 33) and the RK group (n = 33). The mCHEOPS scores were significantly lower in the RK group at 15 min (P = 0.046). The mCHEOPS scores of the two groups decreased with time, but there was no intergroup interaction. The RS group received more analgesics until 1 h after surgery and the RK group received more analgesics during 1-24 h after surgery. There were no differences in adverse outcomes.
CONCLUSIONS: Topical ropivacaine with ketamine can reduce immediate postoperative pain and analgesic requirement better than ropivacaine alone.

Entities:  

Keywords:  Ketamine; Pain; Pediatric; Tonsillectomy

Mesh:

Substances:

Year:  2017        PMID: 28409242     DOI: 10.1007/s00540-017-2353-z

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  28 in total

1.  Brain stem stroke associated with bupivacaine injection for adenotonsillectomy.

Authors:  R Alsarraf; K C Sie
Journal:  Otolaryngol Head Neck Surg       Date:  2000-04       Impact factor: 3.497

2.  Effects of postoperative, nonsteroidal, antiinflammatory drugs on bleeding risk after tonsillectomy: meta-analysis of randomized, controlled trials.

Authors:  Emmanuel Marret; Antoine Flahault; Charles-Marc Samama; Francis Bonnet
Journal:  Anesthesiology       Date:  2003-06       Impact factor: 7.892

Review 3.  The role of N-methyl-D-aspartate (NMDA) receptors in pain: a review.

Authors:  Andrei B Petrenko; Tomohiro Yamakura; Hiroshi Baba; Koki Shimoji
Journal:  Anesth Analg       Date:  2003-10       Impact factor: 5.108

4.  Peripheral NMDA and non-NMDA glutamate receptors contribute to nociceptive behaviors in the rat formalin test.

Authors:  E M Davidson; R E Coggeshall; S M Carlton
Journal:  Neuroreport       Date:  1997-03-03       Impact factor: 1.837

5.  Ultrastructural analysis of NMDA, AMPA, and kainate receptors on unmyelinated and myelinated axons in the periphery.

Authors:  R E Coggeshall; S M Carlton
Journal:  J Comp Neurol       Date:  1998-02-02       Impact factor: 3.215

Review 6.  Local anaesthetic for post-tonsillectomy pain: a systematic review and meta-analysis.

Authors:  J Grainger; N Saravanappa
Journal:  Clin Otolaryngol       Date:  2008-10       Impact factor: 2.597

7.  Comparison of topical tramadol and ketamine in pain treatment after tonsillectomy.

Authors:  Umit Y Tekelioglu; Tayfun Apuhan; Akcan Akkaya; Abdullah Demirhan; Isa Yildiz; Tugce Simsek; Uzeyir Gok; Hasan Kocoglu
Journal:  Paediatr Anaesth       Date:  2013-03-23       Impact factor: 2.556

8.  Topical bupivacaine compared to bupivacaine infiltration for post-tonsillectomy pain relief in children: a prospective randomized controlled clinical study.

Authors:  Mehmet Haksever; Süay Özmen; Davut Akduman; Fevzi Solmaz
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-02       Impact factor: 2.503

9.  Topical ketamine and morphine for post-tonsillectomy pain.

Authors:  O Canbay; N Celebi; S Uzun; A Sahin; V Celiker; U Aypar
Journal:  Eur J Anaesthesiol       Date:  2008-01-11       Impact factor: 4.330

10.  An audit of the complications of paediatric tonsillectomy, adenoidectomy and adenotonsillectomy.

Authors:  D Kendrick; K Gibbin
Journal:  Clin Otolaryngol Allied Sci       Date:  1993-04
View more
  5 in total

Review 1.  The Role of miRNAs in Dexmedetomidine's Neuroprotective Effects against Brain Disorders.

Authors:  Codrin-Constantin Burlacu; Maria-Adriana Neag; Andrei-Otto Mitre; Alexandru-Constantin Sirbu; Andrei-Vlad Badulescu; Anca-Dana Buzoianu
Journal:  Int J Mol Sci       Date:  2022-05-13       Impact factor: 6.208

Review 2.  Regional anesthesia to ameliorate postoperative analgesia outcomes in pediatric surgical patients: an updated systematic review of randomized controlled trials.

Authors:  Mark C Kendall; Lucas J Castro Alves; Edward I Suh; Zachary L McCormick; Gildasio S De Oliveira
Journal:  Local Reg Anesth       Date:  2018-11-15

3.  Topical ropivacaine for analgesia of aplasia cutis congenita in newborns with hereditary epidermolysis bullosa.

Authors:  A Chambelland; C Devos; F Casagrande; C Chiaverini
Journal:  Orphanet J Rare Dis       Date:  2020-12-01       Impact factor: 4.123

Review 4.  Clinical Uses of Ketamine in Children: A Narrative Review.

Authors:  Anoushka Bali; Ashujot Kaur Dang; Daniel A Gonzalez; Rajeswar Kumar; Saba Asif
Journal:  Cureus       Date:  2022-07-20

5.  Dexmedetomidine protects PC12 cells from ropivacaine injury through miR-381/LRRC4 /SDF-1/CXCR4 signaling pathway.

Authors:  Ying Xue; Tao Xu; Wei Jiang
Journal:  Regen Ther       Date:  2020-05-21       Impact factor: 3.419

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.